Watchlist for October 28, 2005

As you know, the Nasdaq sliced through its 200-day moving average yesterday. So once again all three major indices are in bear territory. Cash is looking real good right about now...

I just finished reading through Briefing.com's "In Play" page and there's not much feel bullish about today. That makes me think that perhaps it's time to start getting bullish but if MaoXian's sentiment indicator is correct it's still too early for that. I'm tempted to take another long weekend and return after "the Fed" but I'm going to at least hang around for the first couple of hours to see if anything interesting pops up (or down).

Potential swing trades:

See one of the recent 'Chart Reading' posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

Gapping down on disappointing earnings/guidance: DECK -19% (also downgrades from RBC and Lazard), SAPE -16% (also downgrades from RBC and Pru), WEBX -15%, BEBE -11% (also JP Morgam downgrade), IRF -10.4% (also downgrades from JP Morgan and UBS), MXIM -10% (also downgrades from FRB and Pru), IVGN -9.5%, VSEA -8.7% (also Needham downgrade), OSTK -8.3%, MSTR -7.2%, ASMI -6.4%, KLAC -5.4% (down in sympathy: AMAT -1.1%), RSYS -5% (also Kaufman downgrades to Sell), RNWK -4.9%, PQUE -4.5%, COLM -4.5% (also Pru downgrade), BMY -3.8%, EGLE -2.4% (prices secondary)... Other News: QCOM -7.6% (wireless tech cos ask European Commission to investigate QCOM's anti-competitive conduct), MYGN -4.7% (stock offering), SURG -4.2%,
HERO -3.2%.

Gapping Up

Gapping up on strong earnings/guidance: CSTR +19%, ARDI +9.4%, ABB +5.9%, BOT +4.7%, DSCO +4.6% (Surfaxin granted orphan drug designation), SWIR +3.6%, LEXR +3.5%, ELX +2.4%... Other News: IOTN +5.2% (announces preferred stock offering), NVAX +3% (bounces after 19% drop yesterday), ATYT +2.9% (Mad Money mention), GSK +2.7% (inadvertently releases earnings growth data), FITB +2.6%, BIDU +1.8%, BP +1.7%, NOK +1.6%... Under $3: GTW +12% (reports Q3; also Bear STearns upgrade), CNXT +7.3% (reports Q4), JDSU +6.3% (sees Q1 rev above midpoint of guidance).